Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

BACKGROUND: Patients with early stage papillary thyroid carcinoma (PTC), are faced with the decision to either to accept or reject adjuvant radioactive iodine (RAI) treatment after thryroidectomy. This decision is often difficult because of conflicting reports of RAI treatment benefit and medical ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawka, Anna M, Straus, Sharon, Brierley, James D, Tsang, Richard W, Rotstein, Lorne, Rodin, Gary, Gafni, Amiram, Ezzat, Shereen, Thabane, Lehana, Thorpe, Kevin E, Goldstein, David P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917435/
https://www.ncbi.nlm.nih.gov/pubmed/20659341
http://dx.doi.org/10.1186/1745-6215-11-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917435/
https://www.ncbi.nlm.nih.gov/pubmed/20659341
http://dx.doi.org/10.1186/1745-6215-11-81

Ejemplares similares